These results indicate that the transmembrane FGFR4 variants can modulate cell growth and sensitivity to glucocorticoid hormone negative feedback through various STAT3 modifications relevant to human forms of Cushing’s syndrome [30]. The gene discussed is FGFR4; the disease is Cushing syndrome.